Pediatric Crohn’s Disease, Unrealized Height and Diminished Lifetime Earnings

Share
  • Twitter
  • Facebook
  • email
  • StumbleUpon
  • Delicious
  • Google Reader
  • LinkedIn
  • Google Bookmarks

    P1654 Pediatric Crohn’s Disease, Unrealized Height and Diminished Lifetime Earnings

    Russell D. Cohen, MD, FACG

    Russell D. Cohen, MD, FACG

    Author insight from Russell D. Cohen, MD, FACG, University of Chicago, Chicago, IL

    What’s new here and important for clinicians?
    This abstract raises awareness that the impact of active inflammatory bowel disease in childhood may have profound negative implications not only in their physical and emotional development, but also upon their lifetime wage potential.

    What do patients need to know?
    Early treatment with medications that avoid or limit exposure to steroids in childhood may result in better physical and economic outcomes in adulthood.

    Read abstract

    Author Contact
    Russell D. Cohen, MD, FACG
    Professor of Medicine, Pritzker School of Medicine
    Director, Inflammatory Bowel Disease Center
    Co-Director, Advanced IBD Fellowship Program
    The University of Chicago Medicine
    rcohen@medicine.bsd.uchicago.edu

    Related Abstracts

    P573 A Randomized, Controlled Trial of Yoga in Pediatric Inflammatory Bowel Disease: Preliminary Findings


    Media Interview Requests:

    To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000.

    Share
    • Twitter
    • Facebook
    • email
    • StumbleUpon
    • Delicious
    • Google Reader
    • LinkedIn
    • Google Bookmarks